KELLEY WALKER: Open Payments
NPI 1730173790 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,290 in 111 payments from 17 companies in 2025. Trend: 2023 $2,673 · 2024 $2,360 · 2025 $2,290
Food & beverage: $2,290
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $464 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $325 |
| Vanda Pharmaceuticals Inc. | 10 | $273 |
| Axsome Therapeutics, Inc. | 16 | $249 |
| Teva Pharmaceuticals USA, Inc. | 8 | $167 |
| Janssen Pharmaceuticals, Inc | 8 | $146 |
| Otsuka America Pharmaceutical, Inc. | 12 | $146 |
| E.R. Squibb & Sons, L.L.C. | 8 | $138 |
| Alkermes, Inc. | 3 | $67 |
| Lundbeck LLC | 3 | $65 |
Products named: INGREZZA, CAPLYTA, REXULTI, Auvelity, AUSTEDO XR, FANAPT, COBENFY, HETLIOZ.
Industry payments across TN — which companies pay providers there.
